Clermont Université, University Clermont 1, EA 4231, Clermont-Ferrand F-63001, France.
Eur J Med Chem. 2010 May;45(5):2044-7. doi: 10.1016/j.ejmech.2010.01.023. Epub 2010 Jan 20.
A series of imidazo[1,2-a]pyrrolo[2,3-c]pyridines has been prepared and evaluated for their anti-BVDV activities in MDBK cells. From the synthesized analogues bearing modifications of the substituents at positions 2, 3, 7 and 8, compounds 10a, b, 16, 24, 25 and 26 exhibited significant anti-BVDV activities.
已经制备了一系列咪唑并[1,2-a]吡咯并[2,3-c]吡啶,并在 MDBK 细胞中评估了它们抗 BVDV 的活性。在所合成的具有 2、3、7 和 8 位取代基修饰的类似物中,化合物 10a、b、16、24、25 和 26 表现出显著的抗 BVDV 活性。